We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Engineering Recombinant Antibodies into New Formats

Product News   Dec 03, 2019

 
Engineering Recombinant Antibodies into New Formats
FURTHER INFORMATION
 
 
 

Related Product News

Antibody Enters Clinical Trial for Treatment of B Cell Acute Lymphoblastic Leukemia

Product News

IONTAS has been informed that International Biotechnology Center (IBC) Generium has received approval from the Russian Health Authorities to initiate clinical trials with its CD3/CD19 bispecific antibody for the treatment of B Cell Acute Lymphoblastic Leukemia (ALL).

READ MORE

Putting the Spotlight on Developability Platforms

Product News

Abzena is showcasing its new Developability Service at Antibody Engineering & Therapeutics 2019.

READ MORE

Collaboration Aims To Identify Optimized Antibodies for Novel Cancer Targets

Product News

IONTAS has announced it has entered into a collaboration agreement with Adaptate Biotherapeutics, to generate and optimize antibodies for novel immuno-oncology targets.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE